From: Chest dual-energy CT to assess the effects of steroids on lung function in severe COVID-19 patients
 | No-Steroids (n = 17) | Steroids (n = 43) |  | ||
---|---|---|---|---|---|
 | Mean | SD | Mean | SD | Wilcoxon rank-sum test (α = 0.05) |
Age (years) | 62 | 9 | 64 | 9 | 0.37 |
BMI | 31 | 6 | 31 | 6 | 1 |
 | n | % | n | % | Fisher’s exact test (α  = 0.05) |
---|---|---|---|---|---|
Female | 1 | 6 | 11 | 26 | 0.15 |
Clinical history before ICU stay | n | % | n | % | Â |
---|---|---|---|---|---|
Previous pulmonary disease | 5 | 29 | 11 | 26 | 0.76 |
Thrombotic events before ICU | 2 | 7 | 4 | 9 | 1 |
At ICU admission | Mean | SD | Mean | SD | Wilcoxon rank-sum test (α  = 0.05) |
---|---|---|---|---|---|
Respiratory rate (bpm) | 28 | 9 | 28 | 7 | 0.72 |
SAPS 3 | 51 | 7 | 51 | 11 | 0.97 |
Days of COVID-19 symptoms | 11 | 3 | 11 | 3 | 0.84 |
FIO2 | 60 | 13 | 63 | 16 | 0.54 |
pH | 7.46 | 0.05 | 7.45 | 0.06 | 0.56 |
PaCO2 [mm Hg] | 36 | 5 | 35 | 6 | 0.22 |
PaO2/FIO2 ratio [mm Hg] | 138 | 65 | 124 | 36 | 0.88 |
SpO2 [%] | 93 | 3 | 94 | 2 | 0.42 |
AaDO2 [mm Hg] | 326 | 102 | 332 | 106 | 0.9 |
Weight [kg] | 100 | 20 | 96 | 17 | 0.49 |
Dalteparin [IE] /kg | 133 | 45 | 148 | 41 | 0.11 |
 | n | % | n | % | Fisher’s exact test (α  = 0.05) |
---|---|---|---|---|---|
Intubated patients | 5 | 29 | 16 | 37 | 0.77 |
On DECT day | Mean | SD | Mean | SD | Wilcoxon rank-sum test (α  = 0.05) |
---|---|---|---|---|---|
Days from start of symptoms | 16 | 8 | 13 | 6 | 0.45 |
Days from steroids therapy start | 0 | 0 | 4 | 3 |  < 0.01 |
Days of invasive ventilation | 9 | 6 | 6 | 7 | 0.31 |
PEEP [cm H2O] | 12 | 4 | 10 | 4 | 0.08 |
Static compliance | 43 | 24 | 48 | 18 | 0.49 |
Tidal volume [mL]/kg PBW | 8 | 2 | 9 | 4 | 0.37 |
pH | 7.43 | 0.08 | 7.41 | 0.08 | 0.45 |
PaCO2 [mm Hg] | 42 | 12 | 42 | 10 | 0.95 |
PaO2/FIO2 ratio [mm Hg] | 123 | 25 | 132 | 34 | 0.43 |
SpO2 [%] | 93 | 3 | 94 | 2 | 0.86 |
AaDO2 [mm Hg] | 284 | 81 | 267 | 99 | 0.63 |
Weight (kg) | 100 | 21 | 95 | 17 | 0.43 |
Ferritin [µg/l] | 2315 | 1676 | 1694 | 950 | 0.27 |
D-dimer [ng/ml] | 9 | 13 | 5 | 11 | 0.72 |
Interleukin-6 (IL-6) [pg/ml] | 218 | 155 | 40 | 19 | 0.21 |
Factor Xa [KIE/l] | 0.55 | 0.23 | 0.53 | 0.2 | 0.18 |
 | n | % | n | % | Fisher’s exact test (α  = 0.05) |
---|---|---|---|---|---|
Intubated patients | 8 | 47 | 16 | 37 | 0.77 |
Spontaneously breathing patients | 9 | 52 | 27 | 69 | 1 |
Acute thrombotic events before DECT | 7 | 41 | 6 | 14 | 0.03* |
At ICU discharge | Mean | SD | Mean | SD | Wilcoxon rank-sum test (α  = 0.05) |
---|---|---|---|---|---|
Days of invasive ventilation | 12 | 8 | 5 | 3 | 0.14 |
Days of ICU stay | 16 | 6 | 8 | 4 | 0.45 |
Highest ferritin [µg/l] | 5067 | 4257 | 2046 | 1974 | 0.03* |
Highest D-dimer [ng/ml] | 26 | 42 | 10 | 20 | 0.9 |
Highest interleukin-6 (IL-6) [pg/ml] | 449 | 564 | 95 | 71 | 0.01* |
 | n | % | n | % | Fisher’s exact test (α  = 0.05) |
---|---|---|---|---|---|
Alive 30Â days after ICU | 12 | 71 | 31 | 72 | 0.49 |
Invasive mechanical ventilation | 10 | 59 | 22 | 51 | 0.77 |
Thrombotic events | 8 | 47 | 8 | 19 | 0.04* |